Publicly accusing an entity of a cyberattack could have negative consequences that organizations should consider before taking the plunge.
After tumultuous year, Sarepta plots rebound with early data on RNA therapies
Sarepta Therapeutics reported promise in initial findings from clinical studies of two RNA muscle disease treatments, as the company maps out a future beyond its controversial Duchenne muscular dystrophy therapies. Sarepta is developing RNA treatments …
Beam looks to accelerated approval for AATD base editing after promising update
Beam Therapeutics has provided a much-awaited update on its therapy that uses a form of CRISPR called base editing to precisely fix a single genetic typo responsible for a rare genetic disease. On Wednesday,
How pharma marketers can capitalize on HCPs’ AI, social media and streaming habits
A new report from Assembled Intelligence and inVibe sheds light on how HCPs are using digital technologies in their work—and what that means for marketers.
Boehringer Ingelheim plans for dealmaking and R&D spending amid US price pressure
Boehringer Ingelheim said it plans to keep up high levels of R&D spending, and could look at China-based companies for dealmaking, as key planks of its strategic approach this year, board chairman Shashank Deshpande said …
Phishers Pose as Palo Alto Networks’ Recruiters for Months in Job Scam
A series of campaigns that began in August aim to defraud job candidates, using psychological tactics and data scraped from LinkedIn profiles.
Robot-Assisted Therapy for Upper Limb Rehabilitation After Stroke: Umbrella Review
Background: Stroke is a leading cause of long-term upper limb disability, severely impacting patients’ independence and quality of life. Robot-assisted therapy (RAT) has emerged as a promising, high-intensity rehabilitation alternative. However, conclusions from existing systematic reviews on its efficacy are inconsistent and often lack a holistic framework, limiting their use for guiding personalized clinical decisions. […]
SANS: Top 5 Most Dangerous New Attack Techniques to Watch
For the first time, SANS Institute’s five top attack techniques all have one thing in common – AI.
Novo reports more triple-G data from China; Grifols plots IPO for biopharma unit
Plus, news about BrightGene and Apogee Therapeutics: 📊 More data on Novo Nordisk-United triple-G: The Danish drugmaker said its China-derived triple-G agonist led to mean HbA1c reduction of up to …
Grifols board backs IPO for US business
Spanish plasma medicine specialist Grifols is planning to sell a minority stake in its US business, via an IPO, to help pay down its debt.
Why a ‘Near Miss’ Database Is Key to Improving Information Sharing
Organizations disclose attack details, though information may be limited, following a breach, but what if they did the same with close calls?
This startup wants to change how mathematicians do math
Axiom Math, a startup based in Palo Alto, California, has released a free new AI tool for mathematicians, designed to discover mathematical patterns that could unlock solutions to long-standing problems. The tool, called Axplorer, is a redesign of an existing one called PatternBoost that François Charton, now a research scientist at Axiom, co-developed in 2024 […]